Related Experiment Video
Updated: Jun 29, 2026
05:17
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Targeted therapy in non-small cell lung cancer: a commentary
1Department of Anatomic Pathology, Regional Hospital, Venice, Italy. bruno.murer@ulss12.ve.it
Archives of Pathology & Laboratory Medicine
|October 7, 2008
Summary
Targeted therapy shows promise for advanced non-small cell lung cancer (NSCLC). However, improved survival is limited by resistance and selection methods, necessitating further research into epithelial growth factor receptor inhibitors.
Area of Science:
- Oncology
- Pharmacology
Background:
- Targeted therapy offers a promising avenue for advanced non-small cell lung cancer (NSCLC).
- Epithelial growth factor receptor (EGFR) has become a key target in selected NSCLC patients.
Purpose of the Study:
- To review current data on targeted therapy for advanced NSCLC.
- To provide clinical perspectives on the role of targeted therapy.
Main Methods:
- Literature review.
- Author's clinical experience.
Main Results:
- Despite advancements, targeted therapies have not significantly improved overall survival in advanced NSCLC.
- Resistance to therapy and suboptimal patient selection methods may contribute to this lack of improvement.
Conclusions:
- The molecular status of EGFR may not be the sole predictor for targeted therapy efficacy.
- Understanding the interactions between EGFR inhibitors and other molecules is crucial for developing more effective NSCLC treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...